SectorBiological Technology
Established Date30/11/2011
Listing Date12/02/2019
ExchangeNASDAQ Stock Exchange
Full-time Employees12
Fiscal Year Ends31/12
Security TypeDepository Receipts (Ordinary Shares)
Office address10 Habarzel Street, Building C, 10th Floor, Tel Aviv 6158101, Israel
Business
IntroductionChemomab Therapeutics Ltd., was incorporated under the laws of the State of Israel on November 30, 2011. The company is a clinical-stage biotechnology company focused on the development of innovative therapies for fibrotic and inflammatory diseases. Its lead drug candidate, nebokitug, a monoclonal antibody targeting CCL 24, has completed a Phase 2 trial for primary sclerosing cholangitis and plans to conduct a Phase 3 trial.
